In Treatment and prevention of Blood clots H Parin 80mg Injection prevents new blood clots from forming and prevents the existing ones from getting bigger. It works by blocking a substance in the body which is involved in blood clotting. Thus it helps your blood flow smoothly throughout the body. This can help reduce damage caused by clots in your lungs (pulmonary embolism), brain (stroke), heart (heart attack), or other blood vessels (thrombosis). It can also be used to prevent clots from forming after surgery, for example, to replace a knee or hip joint. Although it does not “dissolve” blood clots, it can prevent them from getting bigger so your body can dissolve them over time. It can also make it less likely that parts of a clot will break off and travel to other parts of the body.
It is not known whether it is safe to consume alcohol with H Parin 80mg Injection. Please consult your doctor.
H Parin 80mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
H Parin 80mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. H Parin 80mg Injection is released in small amounts in the breast milk and amounts reaching the baby are also small, which would not be expected to cause any harmful effects to the baby.
H Parin 80mg Injection does not usually affect your ability to drive.
H Parin 80mg Injection should be used with caution in patients with kidney disease. Dose adjustment of H Parin 80mg Injection may be needed. Please consult your doctor.
There is limited information available on the use of H Parin 80mg Injection in patients with liver disease. Please consult your doctor. However, cautious use is advised in patients with underlying liver disease.
If you miss a dose of H Parin 80mg Injection, please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Gland Pharma Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cadila Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Emcure Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Intas Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sanofi India Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Vhb Life Sciences Inc || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Aristo Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Neon Laboratories Ltd || ₹14.5/tablet (25% cheaper)